E-Book | December 21, 2020

Pre Use Post Sterilization Integrity Testing - Considerations In Implementation

Source: CAI

By Jeff J. Gaerke, P.E., Principal Consultant

Pharma Lab Worker

There has been significant debate over the years between regulatory agencies and the pharmaceutical industry regarding the advantages and disadvantages related to patient sterility risk with performing Pre-Use Post-Sterilization Integrity Testing (PUPSIT) of sterilizing-grade filters. This white paper will not add to this specific discussion; instead, the purpose of this document is to provide the reader with items to consider when determining how to implement PUPSIT in a robust manner for their particular application in instances where the decision is to perform PUPSIT.

access the E-Book!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online